← back to search

Xingyuan Wang

Ningbo University · CN
Area of research
Oncology · Surgery
Research interest
Research focused on Clear cell renal cell carcinoma and Cancer research, with related work in Renal cell carcinoma, CD14, Cell growth. Notable publications include 'Bladder cancer cells induce immunosuppression of T cells by supporting PD‐L1 expression in tumour macrophages partially through interleukin 10', 'BMP8A promotes survival and drug resistance via Nrf2/TRIM24 signaling pathway in clear cell renal cell carcinoma', and 'Differentiation of bMSCs on Biocompatible, Biodegradable, and Biomimetic Scaffolds for Largely Defected Tissue Repair'.
h-index
citations
165
works
10
NIH funding
primary concept
email

Recent publications

Pazopanib stimulates senescence of renal carcinoma cells through targeting nuclear factor E2‐related factor 2 (Nrf2)
Journal of Biochemical and Molecular Toxicology 2024cited by 3position: firstdoi
Construction of graphene/AuNPs based amperometric immunosensor for detecting bladder cancer biomarker apolipoprotein A1
Carbon letters 2023cited by 3position: middledoi
Identification of a differentiation-related prognostic nomogram based on single-cell RNA sequencing in clear cell renal cell carcinoma
Scientific Reports 2022cited by 17position: middledoi
Zinc oxide nanoparticles promotes ferroptosis to repress cancer cell survival and inhibits invasion and migration by targeting miR-27a-3p/YAP axis in renal cell carcinoma
Arabian Journal of Chemistry 2022cited by 7position: firstdoi
A pyroptosis-associated signature plays a role in prognosis prediction in clear cell renal cell carcinoma
BMC Medical Genomics 2022cited by 4position: middledoi
Development of a SETD2-related immune prognostic signature in clear cell renal cell carcinoma
Medicine 2022cited by 1position: firstdoi
RHBDD1 promotes proliferation, migration, invasion and EMT in renal cell carcinoma via the EGFR/AKT signaling pathway
Molecular Medicine Reports 2021cited by 12position: middledoi
BMP8A promotes survival and drug resistance via Nrf2/TRIM24 signaling pathway in clear cell renal cell carcinoma
Cancer Science 2020cited by 36position: middledoi
Differentiation of bMSCs on Biocompatible, Biodegradable, and Biomimetic Scaffolds for Largely Defected Tissue Repair
ACS Applied Bio Materials 2019cited by 33position: firstdoi
Bladder cancer cells induce immunosuppression of T cells by supporting PD‐L1 expression in tumour macrophages partially through interleukin 10
Cell Biology International 2016cited by 49position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Zhinan Xia · Harbin Medical University4 papers (2022–2022)Licheng Cai · Harbin Medical University4 papers (2020–2022)Yipeng Yu · Harbin Medical University4 papers (2020–2022)Wengang Jian · Harbin Medical University4 papers (2020–2022)Tengda Wang · Harbin Medical University3 papers (2020–2022)Dechao Li · Harbin Medical University2 papers (2022–2024)Jie Meng · Shanghai Medical College of Fudan University2 papers (2022–2024)Changfu Li · Harbin Medical University2 papers (2022–2024)Lichen Teng · Harbin Medical University2 papers (2022–2024)Wenhao Yao · Shanghai Chest Hospital2 papers (2022–2022)Wei Xue · Harbin Medical University2 papers (2022–2022)Cheng Zhang · Harbin Medical University2 papers (2020–2022)Mi Zhou · Ningbo University1 papers (2019–2019)Yong‐Sheng Chen · Harbin Medical University1 papers (2024–2024)Yongsheng Chen · Iowa State University1 papers (2022–2022)Li Ma · Harbin Medical University1 papers (2016–2016)Zhicheng Jiang · University of Electronic Science and Technology of China1 papers (2022–2022)Liangjun Wei · Harbin Medical University1 papers (2023–2023)Daming Zhang · Shanxi Medical University1 papers (2020–2020)Zhiming Gao · Beijing Institute of Technology1 papers (2021–2021)